UCSF

ZINC03881556

Substance Information

In ZINC since Heavy atoms Benign functionality
October 5th, 2005 26 No

Other Names:

(17beta)-3-Hydroxyestra-1,3,5(10)-trien-17-yl valerate

17-BETA-ESTRADIOL 17-VALERATE; CPD000058346; SAM002564206

17-BETA-ESTRADIOL 17-VALERATE; CPD000058346; SAM002564206; estradiol valerate

17-hydroxy-3-oxo-19-nor-17α-pregna-4,9-diene-21-nitrile

17-pentanoyl-estra-1,3,5(10)-triene-3,17beta-diol

17α-cyanomethyl-17β-hydroxy-estra-4,9(10)-dien-3-one

17β-Estradiol-17-valerate

3-Hydroxy-17beta-valeroyloxyestra-1,3,5(10)-triene; Atladiol; C23H32O3; CCRIS 5571; Climaval; Cyclocur; DELESTROGEN; DITATE-DS; Deladiol; Delahormone unimatic; Delestrogen 4X; Deluteval 2X; Depo estro med; Depo-Estro-Med; Ditate; Dura-estradiol; Duratrad

3-hydroxyestra-1,3,5(10)-trien-17-yl pentanoate

979-32-8; C12859; Estradiol valerate

979-32-8; D01413; Deladumone (TN); Estradiol valerate (JAN/USP/INN)

BAN

Delestrogen

estr-

Estradiol Valerate

Estradiol Valerate (BAN

Estradiol Valerate (FDA

Estradiol valerate/Dienogest

FDA

FDA)

INN

��-Estradiol 17-valerate

JAN

MFCD00056541

N/A

Natazia

Oestradiol valerate

pentanoate d'estra-1,3,5(10)-triène-3-ol-17β-yle

pentanoic acid [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester

pentanoic acid, (17b)-3-hydroxyestra-1,3,5(10)-trien-17-yl ester

QA-9215

Qlaira

USP

USP)

[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate

[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pentanoate valeric acid

¦Â-Estradiol 17-valerate

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 5.56 11.28 -7.13 1 3 0 47 356.506 5

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 6.17e-04 g/l DrugBank-approved
Target Estrogen/progestogen Receptor Selleck Chemicals
Indications hormone replacement therapy KeyOrganics Bioactives
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : E-4694; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: E-4694; SUPPLIER_COMMENTS: WHITE POWDER NIH Clinical Collection via PubChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )